Does VALGANCICLOVIR Cause Thrombotic microangiopathy? 98 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 98 reports of Thrombotic microangiopathy have been filed in association with VALGANCICLOVIR (VALGANCICLOVIR). This represents 1.2% of all adverse event reports for VALGANCICLOVIR.
98
Reports of Thrombotic microangiopathy with VALGANCICLOVIR
1.2%
of all VALGANCICLOVIR reports
50
Deaths
65
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From VALGANCICLOVIR?
Of the 98 reports, 50 (51.0%) resulted in death, 65 (66.3%) required hospitalization, and 2 (2.0%) were considered life-threatening.
Is Thrombotic microangiopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALGANCICLOVIR. However, 98 reports have been filed with the FAERS database.
What Other Side Effects Does VALGANCICLOVIR Cause?
Off label use (1,882)
Cytomegalovirus infection (1,091)
Drug ineffective (886)
Neutropenia (809)
Leukopenia (574)
Drug resistance (524)
Cytomegalovirus viraemia (447)
Pancytopenia (434)
Cytomegalovirus infection reactivation (374)
Death (359)
What Other Drugs Cause Thrombotic microangiopathy?
TACROLIMUS (1,982)
MYCOPHENOLATE MOFETIL (820)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)
Which VALGANCICLOVIR Alternatives Have Lower Thrombotic microangiopathy Risk?
VALGANCICLOVIR vs VALIUM
VALGANCICLOVIR vs VALPROATE
VALGANCICLOVIR vs VALPROIC ACID
VALGANCICLOVIR vs VALPROMIDE
VALGANCICLOVIR vs VALSARTAN